MK-677, also known as Ibutamoren, is a small-molecule research compound supplied in a solid tablet matrix at 25 mg per unit, with 60 tablets per container. Batch-specific Certificates of Analysis document compound identity, net content per tablet, and formulation details, including excipient profile where applicable, to support reproducibility and documentation control.

MK-677 is provided for controlled in-vitro and ex-vivo research investigations. It is commonly used in studies focused on ghrelin receptor pathway characterization, receptor–ligand interaction profiling, and analytical assay development under defined laboratory conditions.

The solid-dose format enables dissolution testing, stability profiling, impurity tracking, and comparative method validation. Representative applications include matrix-assisted delivery modeling, receptor binding and activation studies, and forced-degradation assessments to inform analytical method suitability.

Each production lot is qualified at 99%+ purity using high-performance liquid chromatography, with compound identity confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytics. Manufacturing documentation, including Certificates of Analysis, raw-material provenance, and batch records, is maintained to support traceability, institutional procurement review, and audit readiness.

• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use